Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
16.65
-2.41 (-12.64%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Burning Rock Biotech Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Revenue | 539.57 | 515.82 | 537.44 | 563.24 | 507.86 | Upgrade
|
| Revenue Growth (YoY) | 4.60% | -4.02% | -4.58% | 10.90% | 18.13% | Upgrade
|
| Cost of Revenue | 136.65 | 153.42 | 174.21 | 183.2 | 143.72 | Upgrade
|
| Gross Profit | 402.91 | 362.4 | 363.23 | 380.04 | 364.15 | Upgrade
|
| Selling, General & Admin | 291.27 | 452.54 | 685.53 | 938.58 | 793.35 | Upgrade
|
| Research & Development | 166.49 | 232.29 | 347.02 | 421.87 | 367.86 | Upgrade
|
| Operating Expenses | 457.76 | 684.83 | 1,033 | 1,360 | 1,161 | Upgrade
|
| Operating Income | -54.85 | -322.43 | -669.32 | -980.41 | -797.06 | Upgrade
|
| Interest Expense | -0.03 | - | - | - | -1.54 | Upgrade
|
| Interest & Investment Income | 8.05 | 12.21 | 17.96 | 9.36 | 3.46 | Upgrade
|
| Currency Exchange Gain (Loss) | -6.71 | -0.1 | -0.42 | 1.55 | -0.85 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.26 | 4.71 | 0.48 | 0.25 | 0.2 | Upgrade
|
| EBT Excluding Unusual Items | -53.79 | -305.61 | -651.3 | -969.25 | -795.8 | Upgrade
|
| Asset Writedown | - | -35.13 | - | - | - | Upgrade
|
| Pretax Income | -53.79 | -340.74 | -651.3 | -969.25 | -795.8 | Upgrade
|
| Income Tax Expense | 1.56 | 5.89 | 2.39 | 1.99 | 0.9 | Upgrade
|
| Net Income | -55.35 | -346.63 | -653.69 | -971.23 | -796.7 | Upgrade
|
| Net Income to Common | -55.35 | -346.63 | -653.69 | -971.23 | -796.7 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 10 | 10 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | 4.78% | 0.53% | -1.46% | -0.29% | 51.83% | Upgrade
|
| EPS (Basic) | -5.13 | -33.67 | -63.84 | -93.47 | -76.45 | Upgrade
|
| EPS (Diluted) | -5.13 | -33.67 | -63.84 | -93.47 | -76.45 | Upgrade
|
| Free Cash Flow | -28.44 | -97.68 | -263.89 | -527.1 | -688.81 | Upgrade
|
| Free Cash Flow Per Share | -2.64 | -9.49 | -25.77 | -50.73 | -66.10 | Upgrade
|
| Gross Margin | 74.67% | 70.26% | 67.58% | 67.47% | 71.70% | Upgrade
|
| Operating Margin | -10.17% | -62.51% | -124.54% | -174.07% | -156.94% | Upgrade
|
| Profit Margin | -10.26% | -67.20% | -121.63% | -172.44% | -156.87% | Upgrade
|
| Free Cash Flow Margin | -5.27% | -18.94% | -49.10% | -93.58% | -135.63% | Upgrade
|
| EBITDA | -3.46 | -271.05 | -537.87 | -859.66 | -752.46 | Upgrade
|
| EBITDA Margin | -0.64% | -52.55% | -100.08% | -152.63% | -148.16% | Upgrade
|
| D&A For EBITDA | 51.39 | 51.39 | 131.45 | 120.75 | 44.6 | Upgrade
|
| EBIT | -54.85 | -322.43 | -669.32 | -980.41 | -797.06 | Upgrade
|
| EBIT Margin | -10.17% | -62.51% | -124.54% | -174.07% | -156.94% | Upgrade
|
| Revenue as Reported | - | 515.82 | 537.44 | 563.24 | 507.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.